(PDF) Choroidal Blood Flow After the First Intravitreal

Choroidal Blood Flow After the First Intravitreal Ranibizumab Injection in Neovascular Age-Related Macular Degeneration Patients

Acta Ophthalmologica - United States

doi 10.1111/aos.13763

Full Text

Abstract

Available in full text

Categories

Date

September 10, 2018

Authors

Benjamin Mottet

Martial Henri Geiser

Ahmed Almanjoumi

Christophe Chiquet

Publisher

Wiley

Related search

Peripapillary Choroidal Thickness After Intravitreal Ranibizumab Injections in Eyes With Neovascular Age-Related Macular Degeneration

BMC Ophthalmology

English

Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine

English

Effect of ARMS2 Gene Polymorphism on Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration

Genetics and Molecular Research

Molecular Biology

English

Change in Choroidal Thickness After Intravitreal Aflibercept in Pretreated and Treatment-Naive Eyes for Neovascular Age-Related Macular Degeneration

British Journal of Ophthalmology

Molecular Neuroscience

Sensory Systems

English

Macular Functional Changes in Patients With Neovascular Age-Related Macular Degeneration Receiving Ranibizumab Therapy (Lucentis)

English

Electrophysiologic Changes After Intravitreal Ranibizumab Injection for the Treatment of Choroidal Neovascular Membrane (CNVM)

Clinical Ophthalmology

English

Ranibizumab Monotherapy in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment

Journal of Clinical & Experimental Ophthalmology

English

Ranibizumab in Neovascular Age-Related Macular Degeneration: A 5-Year Follow-Up

Clinical Ophthalmology

English

Cost-Effectiveness of Intravitreal Aflibercept Injection (IAI) in Treating Neovascular Age-Related Macular Degeneration in the US

Value in Health

Occupational Health

English